Stryker group president Dylan Crotty sells $144,914 of stock

Dylan Crotty, President of Stryker Corp, sold 441 shares on August 21, 2026, according to a recent SEC filing. The transaction saw him dispose of the shares at $328.605 each, resulting in a total value of $144,914. Following the sale, Mr. Crotty's ownership of Stryker's stock remains intact, with shares held indirectly through various trusts and accounts.

The company's stock price is now $329.70, reflecting a 5% decline year-to-date. Despite the insider sale, analysts view the stock as potentially undervalued, suggesting upside for investors. Stryker Corporation, a healthcare equipment giant, reported stronger-than-expected second-quarter profits, with adjusted earnings of $3.69 per share on $6.6 billion in revenue.

This beat estimates of $3.49 per share and $6.58 billion in revenue. Stryker's shares recently saw a raise in price target by Wolfe Research to $375, maintaining an "Outperform" rating. The company's organic revenue growth for the first half was approximately 6%, aligning with its full-year guidance of 8.5% to 9%.